Journal article

Narrative review: aspirin resistance and its clinical implications.

Simon Sanderson, Jon Emery, Trevor Baglin, Ann-Louise Kinmonth

Ann Intern Med | Published : 2005

Abstract

Aspirin is currently the most cost-effective drug for the secondary prevention of cardiovascular disease, but treatment failures are relatively common. Several factors have been linked to these recurrent vascular events in patients prescribed aspirin, including smoking, drug interactions, nonadherence, comorbid conditions, and aspirin resistance. The term aspirin resistance has been used to describe not only an absence of the expected pharmacologic effects of aspirin on platelets but also poor clinical outcomes, such as recurrent vascular events, in patients treated with aspirin. Aspirin resistance is perhaps more precisely understood as the phenomenon of measurable, persisting platelet acti..

View full abstract

University of Melbourne Researchers